vs
NextPlat Corp（NXPL）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
NextPlat Corp的季度营收约是RETRACTABLE TECHNOLOGIES INC的1.4倍（$12.8M vs $9.4M），RETRACTABLE TECHNOLOGIES INC净利率更高（-24.9% vs -40.2%，领先15.3%），RETRACTABLE TECHNOLOGIES INC同比增速更快（4.0% vs -21.1%），过去两年RETRACTABLE TECHNOLOGIES INC的营收复合增速更高（11.5% vs -14.4%）
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
NXPL vs RVP — 直观对比
营收规模更大
NXPL
是对方的1.4倍
$9.4M
营收增速更快
RVP
高出25.1%
-21.1%
净利率更高
RVP
高出15.3%
-40.2%
两年增速更快
RVP
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $9.4M |
| 净利润 | $-5.1M | $-2.3M |
| 毛利率 | 14.3% | -16.2% |
| 营业利润率 | -28.9% | -81.7% |
| 净利率 | -40.2% | -24.9% |
| 营收同比 | -21.1% | 4.0% |
| 净利润同比 | -70.6% | -162.3% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXPLRVP
| Q4 25 | $12.8M | $9.4M | ||
| Q3 25 | $13.8M | $10.1M | ||
| Q2 25 | $13.2M | $10.4M | ||
| Q1 25 | $14.5M | $8.3M | ||
| Q4 24 | $16.2M | $9.1M | ||
| Q3 24 | $15.4M | $10.3M | ||
| Q2 24 | $17.0M | $6.0M | ||
| Q1 24 | $17.5M | $7.6M |
净利润NXPLRVP
| Q4 25 | $-5.1M | $-2.3M | ||
| Q3 25 | $-2.2M | $371.0K | ||
| Q2 25 | $-1.8M | $-87.5K | ||
| Q1 25 | $-1.3M | $-10.5M | ||
| Q4 24 | $-3.0M | $3.8M | ||
| Q3 24 | $-4.2M | $-1.9M | ||
| Q2 24 | $-5.3M | $-14.2M | ||
| Q1 24 | $-1.5M | $429.4K |
毛利率NXPLRVP
| Q4 25 | 14.3% | -16.2% | ||
| Q3 25 | 19.9% | 16.7% | ||
| Q2 25 | 21.8% | -1.0% | ||
| Q1 25 | 23.8% | -0.0% | ||
| Q4 24 | 16.8% | -27.5% | ||
| Q3 24 | 23.2% | -0.1% | ||
| Q2 24 | 34.5% | -7.0% | ||
| Q1 24 | 27.8% | 25.0% |
营业利润率NXPLRVP
| Q4 25 | -28.9% | -81.7% | ||
| Q3 25 | -14.5% | -36.2% | ||
| Q2 25 | -13.8% | -49.1% | ||
| Q1 25 | -10.2% | -56.4% | ||
| Q4 24 | -14.1% | -79.6% | ||
| Q3 24 | -52.1% | -49.6% | ||
| Q2 24 | -64.1% | -95.6% | ||
| Q1 24 | -10.5% | -39.3% |
净利率NXPLRVP
| Q4 25 | -40.2% | -24.9% | ||
| Q3 25 | -15.9% | 3.7% | ||
| Q2 25 | -13.5% | -0.8% | ||
| Q1 25 | -9.2% | -126.6% | ||
| Q4 24 | -18.6% | 41.6% | ||
| Q3 24 | -27.4% | -18.6% | ||
| Q2 24 | -31.3% | -234.9% | ||
| Q1 24 | -8.5% | 5.7% |
每股收益（稀释后）NXPLRVP
| Q4 25 | — | $-0.09 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | $-0.05 | $-0.35 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.22 | $-0.07 | ||
| Q2 24 | — | $-0.48 | ||
| Q1 24 | $-0.08 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.7M | $2.6M |
| 总债务越低越好 | $1.3M | $895.6K |
| 股东权益账面价值 | $17.3M | $74.4M |
| 总资产 | $27.5M | $142.6M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资NXPLRVP
| Q4 25 | $13.7M | $2.6M | ||
| Q3 25 | $13.9M | $3.4M | ||
| Q2 25 | $16.6M | $3.0M | ||
| Q1 25 | $17.7M | $3.4M | ||
| Q4 24 | $20.0M | $4.2M | ||
| Q3 24 | $20.4M | $3.9M | ||
| Q2 24 | $24.9M | $6.9M | ||
| Q1 24 | $23.5M | $10.0M |
总债务NXPLRVP
| Q4 25 | $1.3M | $895.6K | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.4M | $1.2M | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.4M | — |
股东权益NXPLRVP
| Q4 25 | $17.3M | $74.4M | ||
| Q3 25 | $21.4M | $76.8M | ||
| Q2 25 | $23.5M | $76.5M | ||
| Q1 25 | $25.3M | $76.6M | ||
| Q4 24 | $27.3M | $87.2M | ||
| Q3 24 | $22.5M | $83.5M | ||
| Q2 24 | $26.5M | $85.4M | ||
| Q1 24 | $31.2M | $99.7M |
总资产NXPLRVP
| Q4 25 | $27.5M | $142.6M | ||
| Q3 25 | $30.0M | $146.4M | ||
| Q2 25 | $31.0M | $147.1M | ||
| Q1 25 | $35.2M | $149.3M | ||
| Q4 24 | $37.1M | $160.7M | ||
| Q3 24 | $41.1M | $157.8M | ||
| Q2 24 | $51.5M | $160.7M | ||
| Q1 24 | $65.1M | $176.0M |
负债/权益比NXPLRVP
| Q4 25 | 0.07× | 0.01× | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | 0.01× | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-302.0K | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $-339.0K | — |
| 自由现金流率自由现金流/营收 | -2.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NXPLRVP
| Q4 25 | $-302.0K | $-596.5K | ||
| Q3 25 | $-2.7M | $-1.3M | ||
| Q2 25 | $-1.0M | $-3.7M | ||
| Q1 25 | $-2.1M | $-1.5M | ||
| Q4 24 | $-476.0K | $-1.1M | ||
| Q3 24 | $-4.6M | $-5.7M | ||
| Q2 24 | $2.3M | $-2.7M | ||
| Q1 24 | $-2.7M | $-2.0M |
自由现金流NXPLRVP
| Q4 25 | $-339.0K | — | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $-1.1M | $-4.1M | ||
| Q1 25 | $-2.1M | $-1.6M | ||
| Q4 24 | $-508.0K | $-1.4M | ||
| Q3 24 | $-4.7M | $-6.5M | ||
| Q2 24 | $2.2M | $-2.8M | ||
| Q1 24 | $-2.7M | $-2.2M |
自由现金流率NXPLRVP
| Q4 25 | -2.6% | — | ||
| Q3 25 | — | -13.4% | ||
| Q2 25 | -8.0% | -38.9% | ||
| Q1 25 | -14.3% | -18.8% | ||
| Q4 24 | -3.1% | -15.5% | ||
| Q3 24 | -30.6% | -63.0% | ||
| Q2 24 | 13.2% | -46.8% | ||
| Q1 24 | -15.7% | -29.6% |
资本支出强度NXPLRVP
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.1% | 3.2% | ||
| Q1 25 | 0.2% | 1.0% | ||
| Q4 24 | 0.2% | 3.3% | ||
| Q3 24 | 0.6% | 7.7% | ||
| Q2 24 | 0.4% | 2.0% | ||
| Q1 24 | 0.4% | 3.0% |
现金转化率NXPLRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NXPL
| Healthcare Operations | $9.0M | 70% |
| Ecommerce Revenue | $3.8M | 30% |
RVP
暂无分部数据
